Loading…
Concrete and Asphalt Innovation Act of 2025
Legislative Progress
Introduced
March 13, 2025
Latest Action
March 13, 2025
Primary Sponsor
Christopher A. CoonsDemocratic(DE)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (18)
Read twice and referred to the Committee on Energy and Natural Resources.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Environment/Superfund
S.1067, Concrete and Asphalt Innovation Act of 2025. S. 1323, The Facilitating Increased Resilience, Environmental Weatherization And Lowered Liability (FIREWALL) Act. S. 1325, A bill to amend the IRC of 1986 to impose a fee on certain products imported into the U.S. based on the pollution intensity associated with the products of such products, and for other purposes. S. 5653, Bipartisan American Affordability and Jobs Act of 2026. H.R. 1534, Innovative Mitigation Partnerships for Asphalt and Concrete Technologies Act (IMPACT Act). H.R. 2122, IMPACT Act 2.0. Monitor and engage on federal legislation and administrative action related to carbon capture and sequestration, including 45Q tax credit, and forthcoming project funding. Monitor and engage on federal legislation and administrative action related to 48C tax credit. Monitor and engage on federal legislation and potential modifications to the Resource Conservation and Recovery Act (RCRA), Public Law 94-580. Monitor and engage on federal legislation and administrative action affecting the cement, aggregate, asphalt, and ready mix concrete industries.
Client expense: $260,000 · Firm income: Not reported
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Environment/Superfund
Issues related to energy policy and permitting reforms; H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act; H.R. 6983, Preventing Rate Inflation in Consumer Energy (PRICE) Act; S. 1067, Concrete and Asphalt Innovation Act of 2025
Client expense: $5,880,000 · Firm income: Not reported
2026 · third_quarter · Energy/Nuclear
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Environment/Superfund
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Transportation
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2026 · third_quarter · Energy/Nuclear
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Transportation
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Environment/Superfund
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Energy/Nuclear
Issues related to permitting reforming, including the S. 3947 the REWIRE Act, H.R. 8308, the CERTAIN Act, H.R. 4503/S.3800 ePermit Act and the Bipartisan American Affordability and Jobs Act of 2026 (does not have a bill number yet), issues related to industrial decarbonization, including S. 1067, the Concrete Asphalt Innovation Act, the IMPACT 2.0 (H.R. 2122), and the American Industrial Innovation Act (not yet introduced) - issues related to marine carbon dioxide removal and the S. 3910/H.R. 7656 ReSCUE Oceans Act, issues related to geologic hydrogen on draft bill, and issues related to geothermal energy and S. 4610 the Pacific POWER Act, and issues related to H.R. 9615, the BRACE Act, and issues related to American innovation including the American Leadership in Fusion Act (no bill number yet) and the Better Energy Storage Technology Act (not yet introduced).
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Environment/Superfund
Clean Air Act; National Ambient Air Quality Standards; National Emissions Standards for Hazardous Air Pollutants; Resource Conservation and Recovery Act; Carbon Capture, Utilization, Transmission, and Storage; Permitting Reform; New Source Review Permitting Act (H.R. 161); Resilience; Alternative Fuels; Alternative Fuels Non Hazardous Waste Rule; Coal Combustion Residuals; Implementation of the Inflation Reduction Act (P.L. 117-116); Implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); IMPACT Act (HR 1534); Concrete and Asphalt Innovation Act (S. 1067); Portland Cement National Emissions Standards for Hazardous Air Pollutants; Coal Ash for Infrastructure Act (H.R. 4875); SPEED Act (H.R. 4776); Reauthorization of EPA Water Infrastructure Programs; H.R.4214: Clean Air and Building Infrastructure Improvement Act; H.R.4218: Clean Air and Economic Advancement Reform (CLEAR) Act; H.R.6409: Foreign Emissions & Nonattainment Clarification for Economic Stability(FENCES) Act; H.R.6398: Reducing and Eliminating Duplicative Environmental Regulations (RED Tape) Act; H.R.6387: Fire Improvement and Reforming Exceptional Events (FIRE) Act; Executive Order - Seeking Federal Recognition of Cement as a Critical National Security Material; Reforming Cement Manufacturing for Enhanced Material Efficiency and New Technology Act, ReCement Act (H.R. 9293); Bipartisan American Affordability and Jobs Act (S. 5653); American Energy and Mineral Infrastructure Act (S. 4944)
Client expense: $390,000 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2026 · third_quarter · Manufacturing
HOUSE: H.R. 2122: IMPACT Act 2.0 (Support) SENATE: S. 1067: Concrete and Asphalt Innovation Act (Support) NYI: NYI: Steel Modernization Act (Support) NYI: Low-Emissions steel and iron bill (Support)
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Environment/Superfund
Clean Air Act; National Ambient Air Quality Standards; National Emissions Standards for Hazardous Air Pollutants; Resource Conservation and Recovery Act; Carbon Capture, Utilization, Transmission, and Storage; Permitting Reform; New Source Review Permitting Act (H.R. 161); Resilience; Alternative Fuels; Coal Combustion Residuals; Implementation of the Inflation Reduction Act (P.L. 117-116); Implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); IMPACT Act (HR 1534); Concrete and Asphalt Innovation Act (S. 1067); Portland Cement National Emissions Standards for Hazardous Air Pollutants. Modernize NSR permitting through H.R.161, the New Source Review Permitting Act, to support modernization, efficiency, and emissions-reducing projects. Improve NAAQS implementation through H.R.6387, Fire Improvement and Reforming Exceptional Events (FIRE) Act, and H.R. 6409, Foreign Emissions & Non-attainment Clarification for Economic Stability (FENCES) Act, to address wildfire and foreign emissions outside manufacturers control. H.R. 9293 - Reforming Cement Manufacturing for Enhanced Material Efficiency and New Technology Act (ReCement Act.)
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Transportation
Truck Size & Weight Policies Workforce Development Buy America Domestic Procurement Policy Low Carbon Procurement Surface Reauthorization H.R. 2122 IMPACT Act 2.0 S. 1067 Concrete and Asphalt Innovation Act Build America 250 Act Water Resources Development Act 2026 Permitting Reform
Client expense: $102,480 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)
2026 · third_quarter · Environment/Superfund
Performance Based Specifications Sustainable Building Materials Program H.R. 1534 IMPACT Act S. 1067 Concrete and Asphalt Innovation Act Coal Combustion Residuals (Coal Ash) Rule
Client expense: $102,480 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Environment/Superfund
S.1067, Concrete and Asphalt Innovation Act of 2025. S. 1323, The Facilitating Increased Resilience, Environmental Weatherization And Lowered Liability (FIREWALL) Act. S. 1325, A bill to amend the IRC of 1986 to impose a fee on certain products imported into the U.S. based on the pollution intensity associated with the products of such products, and for other purposes. H.R. 1534, Innovative Mitigation Partnerships for Asphalt and Concrete Technologies Act (IMPACT Act). H.R. 2122, IMPACT Act 2.0. Monitor and engage on federal legislation and administrative action related to carbon capture and sequestration, including 45Q tax credit, and forthcoming project funding. Monitor and engage on federal legislation and administrative action related to 48C tax credit. Monitor and engage on federal legislation and administrative action affecting the cement, aggregate, asphalt, and ready mix concrete industries.
Client expense: $190,000 · Firm income: Not reported
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Environment/Superfund
S.1067, Concrete and Asphalt Innovation Act of 2025. S. 1323, The Facilitating Increased Resilience, Environmental Weatherization And Lowered Liability (FIREWALL) Act. S. 1325, A bill to amend the IRC of 1986 to impose a fee on certain products imported into the U.S. based on the pollution intensity associated with the products of such products, and for other purposes. H.R. 1534, Innovative Mitigation Partnerships for Asphalt and Concrete Technologies Act (IMPACT Act). H.R. 2122, IMPACT Act 2.0. Monitor and engage on federal legislation and administrative action related to carbon capture and sequestration, including 45Q tax credit, and forthcoming project funding. Monitor and engage on federal legislation and administrative action related to 48C tax credit. Monitor and engage on federal legislation and administrative action affecting the cement, aggregate, asphalt, and ready mix concrete industries.
Client expense: $200,000 · Firm income: Not reported
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Environment/Superfund
Issues related to energy policy and permitting reforms; H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act; H.R. 6983, Preventing Rate Inflation in Consumer Energy (PRICE) Act; S. 1067, Concrete and Asphalt Innovation Act of 2025
Client expense: $5,990,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2026 · second_quarter · Environment/Superfund
Performance Based Specifications Sustainable Building Materials Program H.R. 1534 IMPACT Act S. 1067 Concrete and Asphalt Innovation Act Coal Combustion Residuals (Coal Ash) Rule
Client expense: $102,480 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Transportation
Truck Size & Weight Policies Workforce Development Buy America Domestic Procurement Policy Low Carbon Procurement Surface Reauthorization H.R. 2122 IMPACT Act 2.0 S. 1067 Concrete and Asphalt Innovation Act Build America 250 Act Water Resources Development Act 2026
Client expense: $102,480 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)
2026 · second_quarter · Natural Resources
General issues affecting the building materials industry; resilient construction; S.1870/H.R. 3874, Rim of the Valley Corridor Preservation Act; S. 1067, the Concrete and Asphalt Innovation Act; S. 495/H.R. 1163, PROVE IT Act of 2025.
Client expense: Not reported · Firm income: $35,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Environment/Superfund
Clean Air Act; National Ambient Air Quality Standards; National Emissions Standards for Hazardous Air Pollutants; Resource Conservation and Recovery Act; Carbon Capture, Utilization, Transmission, and Storage; Permitting Reform; New Source Review Permitting Act (H.R. 161); Resilience; Alternative Fuels; Coal Combustion Residuals; Implementation of the Inflation Reduction Act (P.L. 117-116); Implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); IMPACT Act (HR 1534); Concrete and Asphalt Innovation Act (S. 1067); Portland Cement National Emissions Standards for Hazardous Air Pollutants. Modernize NSR permitting through H.R.161, the New Source Review Permitting Act, to support modernization, efficiency, and emissions-reducing projects. Improve NAAQS implementation through H.R.6387, Fire Improvement and Reforming Exceptional Events (FIRE) Act, and H.R. 6409, Foreign Emissions & Non-attainment Clarification for Economic Stability (FENCES) Act, to address wildfire and foreign emissions outside manufacturers control. H.R. 9293 - Reforming Cement Manufacturing for Enhanced Material Efficiency and New Technology Act (ReCement Act.)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Environment/Superfund
Clean Air Act; National Ambient Air Quality Standards; National Emissions Standards for Hazardous Air Pollutants; Resource Conservation and Recovery Act; Carbon Capture, Utilization, Transmission, and Storage; Permitting Reform; New Source Review Permitting Act (H.R. 161); Resilience; Alternative Fuels; Alternative Fuels Non Hazardous Waste Rule; Coal Combustion Residuals; Implementation of the Inflation Reduction Act (P.L. 117-116); Implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); IMPACT Act (HR 1534); Concrete and Asphalt Innovation Act (S. 1067); Portland Cement National Emissions Standards for Hazardous Air Pollutants; Coal Ash for Infrastructure Act (H.R. 4875); SPEED Act (H.R. 4776); Reauthorization of EPA Water Infrastructure Programs; H.R.4214: Clean Air and Building Infrastructure Improvement Act; H.R.4218: Clean Air and Economic Advancement Reform (CLEAR) Act; H.R.6409: Foreign Emissions & Nonattainment Clarification for Economic Stability(FENCES) Act; H.R.6398: Reducing and Eliminating Duplicative Environmental Regulations (RED Tape) Act; H.R.6387: Fire Improvement and Reforming Exceptional Events (FIRE) Act; Executive Order - Seeking Federal Recognition of Cement as a Critical National Security Material; Reforming Cement Manufacturing for Enhanced Material Efficiency and New Technology Act, ReCement Act (H.R. 9293)
Client expense: $360,000 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2026 · second_quarter · Transportation
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Environment/Superfund
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Energy/Nuclear
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Energy/Nuclear
Issues related to permitting reforming, including the S. 3947 the REWIRE Act, H.R. 8308, the CERTAIN Act, and the Senate Democrat discussion draft on transmission reform (not yet introduced), issues related to industrial decarbonization, including S. 1067, the Concrete Asphalt Innovation Act, the IMPACT 2.0 (H.R. 2122), and the American Industrial Innovation Act (not yet introduced) - issues related to marine carbon dioxide removal and the S. 3910/H.R. 7656 ReSCUE Oceans Act, issues related to geologic hydrogen on draft bill, and issues related to geothermal energy and S. 4610 the Pacific POWER Act, and issues related to securing an American critical material and battery supply chain (no specific bill).
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Manufacturing
HOUSE: H.R. 2122: IMPACT Act 2.0 (Support) SENATE: S. 1067: Concrete and Asphalt Innovation Act (Support) NYI: NYI: Steel Modernization Act (Support) NYI: Low-Emissions steel and iron bill (Support)
Client expense: $100,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Environment/Superfund
S.1067, Concrete and Asphalt Innovation Act of 2025. S. 1323, The Facilitating Increased Resilience, Environmental Weatherization And Lowered Liability (FIREWALL) Act. S. 1325, A bill to amend the IRC of 1986 to impose a fee on certain products imported into the U.S. based on the pollution intensity associated with the products of such products, and for other purposes. H.R. 1534, Innovative Mitigation Partnerships for Asphalt and Concrete Technologies Act (IMPACT Act). H.R. 2122, IMPACT Act 2.0. Monitor and engage on federal legislation and administrative action related to carbon capture and sequestration, including 45Q tax credit, and forthcoming project funding. Monitor and engage on federal legislation and administrative action related to 48C tax credit. Monitor and engage on federal legislation and administrative action affecting the cement, aggregate, asphalt, and ready mix concrete industries.
Client expense: $290,000 · Firm income: Not reported
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Natural Resources
General issues affecting the building materials industry; resilient construction; S.1870/H.R. 3874, Rim of the Valley Corridor Preservation Act; S. 1067, the Concrete and Asphalt Innovation Act; S. 495/H.R. 1163, PROVE IT Act of 2025.
Client expense: Not reported · Firm income: $35,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Transportation
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Environment/Superfund
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Energy/Nuclear
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Manufacturing
HOUSE: H.R. 2122: IMPACT Act 2.0 (Support) SENATE: S. 1067: Concrete and Asphalt Innovation Act (Support) NYI: NYI: Steel Modernization Act (Support) NYI: Low-Emissions steel and iron bill (Support)
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2026 · first_quarter · Environment/Superfund
Clean Air Act; National Ambient Air Quality Standards; National Emissions Standards for Hazardous Air Pollutants; Resource Conservation and Recovery Act; Carbon Capture, Utilization, Transmission, and Storage; Permitting Reform; New Source Review Permitting Act (H.R. 161); Resilience; Alternative Fuels; Coal Combustion Residuals; Implementation of the Inflation Reduction Act (P.L. 117-116); Implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); IMPACT Act (HR 1534); Concrete and Asphalt Innovation Act (S. 1067); Portland Cement National Emissions Standards for Hazardous Air Pollutants
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Environment/Superfund
Clean Air Act; National Ambient Air Quality Standards; National Emissions Standards for Hazardous Air Pollutants; Resource Conservation and Recovery Act; Carbon Capture, Utilization, Transmission, and Storage; Permitting Reform; New Source Review Permitting Act (H.R. 161); Resilience; Alternative Fuels; Alternative Fuels Non Hazardous Waste Rule; Coal Combustion Residuals; Implementation of the Inflation Reduction Act (P.L. 117-116); Implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); IMPACT Act (HR 1534); Concrete and Asphalt Innovation Act (S. 1067); Portland Cement National Emissions Standards for Hazardous Air Pollutants; One, Big, Beautiful Bill Act (H.R. 1); Coal Ash for Infrastructure Act (H.R. 4875); SPEED Act (H.R. 4776); Reauthorization of EPA Water Infrastructure Programs; H.R.4214: Clean Air and Building Infrastructure Improvement Act; H.R.4218: Clean Air and Economic Advancement Reform (CLEAR) Act; H.R.6409: Foreign Emissions & Nonattainment Clarification for Economic Stability(FENCES) Act; H.R.6398: Reducing and Eliminating Duplicative Environmental Regulations (RED Tape) Act; H.R.6387: Fire Improvement and Reforming Exceptional Events (FIRE) Act; Executive Order - Seeking Federal Recognition of Cement as a Critical National Security Material
Client expense: $360,000 · Firm income: Not reported
Government targets: Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
2026 · first_quarter · Transportation
Truck Size & Weight Policies Workforce Development Buy America Domestic Procurement Policy Low Carbon Procurement Surface Reauthorization H.R. 2122 IMPACT Act 2.0 S. 1067 Concrete and Asphalt Innovation Act
Client expense: $102,480 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)
2026 · first_quarter · Environment/Superfund
Performance Based Specifications Sustainable Building Materials Program H.R. 1534 IMPACT Act S. 1067 Concrete and Asphalt Innovation Act
Client expense: $102,480 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK]
Client expense: $265,983 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Energy/Nuclear
S.1067 Concrete and Asphalt Innovation Act of 2025
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2025 · fourth_quarter · Science/Technology
S.1067 Concrete and Asphalt Innovation Act of 2025
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2025 · fourth_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK] H.R.6609 - Pharmacists Fight Back in Medicare and Medicaid Act To amend titles XI, XVIII, and XIX of the Social Security Act to establish certain requirements under Medicare and Medicaid with respect to prescription drug benefits and pharmacy benefit managers. Sponsor: Rep. Auchincloss, Jake [D-MA-4] H.R.6610 - Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes. Sponsor: Rep. Auchincloss, Jake [D-MA-4]
Client expense: $90,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
2025 · fourth_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK] H.R.6609 - Pharmacists Fight Back in Medicare and Medicaid Act To amend titles XI, XVIII, and XIX of the Social Security Act to establish certain requirements under Medicare and Medicaid with respect to prescription drug benefits and pharmacy benefit managers. Sponsor: Rep. Auchincloss, Jake [D-MA-4] H.R.6610 - Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes. Sponsor: Rep. Auchincloss, Jake [D-MA-4]
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office
2025 · fourth_quarter · Pharmacy
340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] H.R.1262 - Mikaela Naylon Give Kids a Chance Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10] S.932 - Give Kids a Chance Act of 2025 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. Sponsor: Sen. Mullin, Markwayne [R-OK] H.R.6609 - Pharmacists Fight Back in Medicare and Medicaid Act To amend titles XI, XVIII, and XIX of the Social Security Act to establish certain requirements under Medicare and Medicaid with respect to prescription drug benefits and pharmacy benefit managers. Sponsor: Rep. Auchincloss, Jake [D-MA-4] H.R.6610 - Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] To amend chapter 89 of title 5, United States Code, to limit the costs of pharmacy benefit managers with respect to Federal employee health benefit plans, and for other purposes. Sponsor: Rep. Auchincloss, Jake [D-MA-4]
Client expense: $1,440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2025 · fourth_quarter · Transportation
Truck Size & Weight Policies Workforce Development Buy America Domestic Procurement Policy Low Carbon Procurement Surface Reauthorization H.R. 2122 IMPACT Act 2.0 S. 1067 Concrete and Asphalt Innovation Act
Client expense: $56,280 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)
2025 · fourth_quarter · Environment/Superfund
S.1067, Concrete and Asphalt Innovation Act of 2025. S. 1323, The Facilitating Increased Resilience, Environmental Weatherization And Lowered Liability (FIREWALL) Act. S. 1325, A bill to amend the IRC of 1986 to impose a fee on certain products imported into the U.S. based on the pollution intensity associated with the products of such products, and for other purposes. H.R. 1534, Innovative Mitigation Partnerships for Asphalt and Concrete Technologies Act (IMPACT Act). H.R. 2122, IMPACT Act 2.0. Monitor and engage on federal legislation and administrative action related to carbon capture and sequestration, including 45Q tax credit, and forthcoming project funding. Monitor and engage on federal legislation and administrative action related to 48C tax credit. Monitor and engage on federal legislation and administrative action affecting the cement, aggregate, asphalt, and ready mix concrete industries.
Client expense: $160,000 · Firm income: Not reported
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Manufacturing
HOUSE: H.R. 2122: IMPACT Act 2.0 (Support) SENATE: S. 1067: Concrete and Asphalt Innovation Act (Support) NYI: NYI: Steel Modernization Act (Support) NYI: Low-Emissions steel and iron bill (Support)
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2025 · fourth_quarter · Pharmacy
Issues: 340B Program/Transparency; generics access; Pharmacy Benefit Managers; Prescription Drug Cost; Step Therapy Bills: S.1954 - Biosimilar Red Tape Elimination Act To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT] S. 775, Increasing Transparency in Generic Drug Applications To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.3839 - To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2] S. 1067, Ensuring Timely Access to Generics Act (118th) To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH] S.1041 - Affordable Prescriptions for Patients Act A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. Cornyn, John [R-TX] S.1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen. Klobuchar, Amy [D-MN] S.1097 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Sen. Durbin, Richard J. [D-IL] H.R.4570 - Interagency Patent Coordination and Improvement Act of 2025 To amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep. Neguse, Joe [D-CO-2] S.2658 - Medication Affordability and Patent Integrity Act To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office. Sponsor: Sen. Hassan, Margaret Wood [D-NH] S.1302 - Increasing Transparency in Generic Drug Applications Act To provide for increased transparency in generic drug applications. Sponsor: Sen. Hassan, Margaret Wood [D-NH] H.R.1843 - Increasing Transparency in Generic Drug Applications Act To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. Sponsor: Rep. Dunn, Neal P. [R-FL-2]
Client expense: $28,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Natural Resources
General issues affecting the building materials industry; resilient construction; S.1870/H.R. 3874, Rim of the Valley Corridor Preservation Act; S. 1067, the Concrete and Asphalt Innovation Act; S. 495/H.R. 1163, PROVE IT Act of 2025.
Client expense: Not reported · Firm income: $35,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Environment/Superfund
Clean Air Act; National Ambient Air Quality Standards; National Emissions Standards for Hazardous Air Pollutants; Resource Conservation and Recovery Act; Carbon Capture, Utilization, Transmission, and Storage; Permitting Reform; New Source Review Permitting Act (H.R. 161); Resilience; Alternative Fuels; Coal Combustion Residuals; Implementation of the Inflation Reduction Act (P.L. 117-116); Implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); IMPACT Act (HR 1534); Concrete and Asphalt Innovation Act (S. 1067); Portland Cement National Emissions Standards for Hazardous Air Pollutants
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Energy/Nuclear
Advocate on issues related to innovative cement and critical mineral production, including H.R.2122 - IMPACT Act 2.0 and S.1067 - Concrete and Asphalt Innovation Act of 2025. Advocate supporting Brimstone's OCED grant project.
Client expense: Not reported · Firm income: $80,000
Government targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE